Author

Baobing Zhao

Primary ORCID profile (0000-0001-8522-4764 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Baobing ZhaoiD1 paper · Shandong University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Bin XuiD· 1 shared Cheng Zou· 1 shared Dingxiao ZhangiD· 1 shared Lanxin Hu· 1 shared Miaomiao Xu· 1 shared Qinju He· 1 shared Rongrong He· 1 shared Shuchao Ren· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bin XuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

VARS1 fuels prostate cancer evolution via codon-selective translational rewiring

Qinju He, Rongrong He, Yingying Li, Miaomiao Xu, Shuchao Ren, Cheng Zou, Zhenyu Li, Wenchao Li, Yuanzhen Zhang, Lanxin Hu, Bin Xu, Baobing Zhao, Zhipeng Zhou, Dingxiao Zhang

This study identifies VARS1 as a driver of prostate cancer progression by altering codon usage in translation, showing that targeting VARS1 can suppress tumor growth through dietary valine restriction or inhibitors.

bioRxiv · Dec 12, 2025 · PreprintCancer Biology